Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Limes Schlosskliniken AG has the GF Score of 93, which implies that the company
might have
Highest outperformance potential.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Based on research and backtesting result, GuruFocus believes Limes Schlosskliniken AG
might have
Highest outperformance potential.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Limes Schlosskliniken AG (XTER:LIK) GF Score Explanation
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score
Performance Potential and All-in-One Screener Examples (1)
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
Limes Schlosskliniken AG GF Score Related Terms
XTER:LIK vs HCA, THC, DVA: GF Score Comparison
For the Medical Care Facilities subindustry, Limes Schlosskliniken AG's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Limes Schlosskliniken AG GF Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Limes Schlosskliniken AG's GF Score distribution charts can be found below:
* The bar in red indicates where Limes Schlosskliniken AG's GF Score falls into.
Limes Schlosskliniken AG (XTER:LIK) has a GF Score of 93 as of Jul. 17, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Limes Schlosskliniken AG and its competitors. This is 66% above median its historical median of 56.00. Over the past decade, Limes Schlosskliniken AG's GF Score has ranged from 8.00 to 92.00.
Is Limes Schlosskliniken AG's GF Score too high?
Limes Schlosskliniken AG's current GF Score of 93 is 66% above median its 10-year median of 56.00. Over the past 10 years, this metric has ranged from a low of 8.00 to a high of 92.00. Overall, Limes Schlosskliniken AG has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Limes Schlosskliniken AG's GF Score compare to HCA and THC?
Limes Schlosskliniken AG's GF Score of 93 can be compared against companies in the Healthcare Providers & Services industry. Historically, Limes Schlosskliniken AG's own GF Score has ranged from 8.00 to 92.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Healthcare Providers & Services company?
A good GF Score depends on the Healthcare Providers & Services industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Limes Schlosskliniken AG and its competitors. Limes Schlosskliniken AG's current GF Score is 93, which is 66% above median its own 10-year median of 56.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Limes Schlosskliniken AG stock overvalued right now?
Based on GuruFocus' analysis, Limes Schlosskliniken AG (XTER:LIK) is currently considered Fairly Valued. The stock's GF Value™ is €518.60, compared to a current price of €545.00 — trading 5.1% above its estimated fair value. The current GF Score is 93, which is 66% above median its 10-year median of 56.00. Limes Schlosskliniken AG's overall GF Score™ is 93/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Limes Schlosskliniken AG (XTER:LIK), the current GF Score is 93 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Limes Schlosskliniken AG (XTER:LIK) Overvalued in 2026?
Based on GuruFocus' analysis, Limes Schlosskliniken AG stock appears to be overvalued.
The current stock price of €545.00 is trading 5.1% above its estimated GF Value™ of €518.60.
GuruFocus considers Limes Schlosskliniken AG to be Fairly Valued.
Key valuation signals for XTER:LIK:
GF Score: 93 (66% above median its 10-year median of 56.00)
GF Value™: €518.60 vs. price of €545.00 (5.1% above fair value)
No single metric tells the full story. See the XTER:LIK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Limes Schlosskliniken AG operates mental and psychosomatic mental health clinic. It specializes in the treatment of stress disorders including depressions, Burnout Syndrome, Posttraumatic stress disorder, Anxiety / obsessive-compulsive disorder, eating disorders, personality disorders, and Somatization disorders such as chronic pain. LIMES Schlosskliniken operates in the market for high-quality private hospitals specializing in psychiatry, psychotherapy, and psychosomatics in Germany and Switzerland.
93GF Score
Get the complete analysis for XTER:LIK
GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:LIK has been successfully added to your 
